New eczema drug shows promise in early trial
NCT ID NCT06585202
First seen Mar 13, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This study tested an experimental drug called ATI-2138 in 14 adults with moderate to severe atopic dermatitis (eczema). Participants took the drug for 12 weeks to see if it was safe and could improve their skin symptoms. The main goal was to check for side effects, while also measuring changes in eczema severity and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aclaris Investigational Site
Birmingham, Alabama, 35244, United States
-
Aclaris Investigational Site
Encino, California, 91436, United States
-
Aclaris Investigational Site
San Diego, California, 92123, United States
-
Aclaris Investigational Site
Plainfield, Indiana, 46168, United States
-
Aclaris Investigational Site
Austin, Texas, 78759, United States
-
Aclaris Investigational Site
San Antonio, Texas, 78213, United States
Conditions
Explore the condition pages connected to this study.